Australia markets close in 1 hour 24 minutes

Immunome, Inc. (IMNM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
15.46-0.29 (-1.84%)
At close: 04:00PM EDT
15.80 +0.34 (+2.20%)
After hours: 07:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 925.83M
Enterprise value 785.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)21.86
Price/book (mrq)7.72
Enterprise value/revenue 56.02
Enterprise value/EBITDA -28.05

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3152.00%
S&P500 52-week change 324.49%
52-week high 330.96
52-week low 34.50
50-day moving average 321.09
200-day moving average 312.83

Share statistics

Avg vol (3-month) 3806.08k
Avg vol (10-day) 3914.87k
Shares outstanding 559.94M
Implied shares outstanding 659.94M
Float 844.1M
% held by insiders 118.02%
% held by institutions 140.44%
Shares short (15 Apr 2024) 43.75M
Short ratio (15 Apr 2024) 46.26
Short % of float (15 Apr 2024) 46.64%
Short % of shares outstanding (15 Apr 2024) 46.28%
Shares short (prior month 15 Mar 2024) 43.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-362.02%

Management effectiveness

Return on assets (ttm)-20.81%
Return on equity (ttm)-156.45%

Income statement

Revenue (ttm)14.02M
Revenue per share (ttm)0.71
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -28.27M
Net income avi to common (ttm)-106.81M
Diluted EPS (ttm)-5.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)142.15M
Total cash per share (mrq)2.38
Total debt (mrq)1.65M
Total debt/equity (mrq)1.38%
Current ratio (mrq)6.63
Book value per share (mrq)2.77

Cash flow statement

Operating cash flow (ttm)-7.57M
Levered free cash flow (ttm)2.36M